+987.9%
MRNA vs AVTR
+37.4%
+950.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AVTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.4% | +12.7% | +12.8% |
| 7D | +20.6% | -6.2% | +26.9% | +26.9% |
| 30D | +27.1% | -1.0% | +28.2% | +28.1% |
| 3M | +353.4% | +14.4% | +339.0% | +306.5% |
| 6M | +446.3% | +95.9% | +350.4% | +277.8% |
| YTD | +776.2% | +36.6% | +739.6% | +651.3% |
| 1Y | +987.9% | +35.1% | +952.8% | +829.8% |
| All | +987.9% | +37.4% | +950.5% | +829.8% |
Cumulative growth
Daily Returns
Daily percentage return beside AVTR.
Daily Out/Under-Performance
Portfolio return minus AVTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AVTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling